German Coronavirus Vaccine Developer CureVac Denies US Bid
CureVac, the German biotech firm at the center of an argument over alleged U.S. attempts to gain access to an experimental coronavirus vaccine it is developing, denied Tuesday it had received U.S. offers for the company or its assets.European Union leaders said they would discuss Tuesday via videoconference how to prevent hostile U.S. takeovers of …
Read more “German Coronavirus Vaccine Developer CureVac Denies US Bid”